ADIPOQ and triple-A syndrome: The adiponectin-mediated inhibition of AAA development has been shown to occur by inhibiting the expression of pro-inflammatory cytokines, limiting aortic infiltration of inflammatory cells and thus reducing inflammation in adipose tissue [30,31].